VDYNE, INC.

MAPLE GROVE, MN · Founded 2017 · Medtech · Private

Minimally invasive medical system for treating tricuspid valve regurgitation

Claim this profile

Follows are private to you and power your alerts

Updated · vdyne.com

Sector
Medtech
Headquarters
MAPLE GROVE, MN
Founded
2017
Latest Form D
$8M, Dec 2020
Total capital
$33M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$33M
4 Form D · last Dec 2020
70 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
25
15 pending · first 2021
Rank in peer group#77 of 1112

Capital timeline

201820192020FEDERAL ↑EQUITY ↓Cumulative $33M1st Form D$5.2M2nd Form D$6.8M3rd Form D$13M
201820192020FEDERAL ↑EQUITY ↓Cumulative $33M2nd Form D$6.8M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$8M
  • Private capital raisedForm D · SEC · 3rd filing$13M
  • Private capital raisedForm D · SEC · 2nd filing$6.8M
  • Private capital raisedForm D · SEC · 1st filing$5.2M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#77 · top 7%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • David McIntyreDirectorNamed in SEC Form D filings
  • Edward W MaloufExecutive Officer, PromoterNamed in SEC Form D filings
  • Greg PearlDirectorNamed in SEC Form D filings
  • Jean-Raymond Boulle IIDirectorNamed in SEC Form D filings
  • Lucian LozonschiDirectorNamed in SEC Form D filings
  • Robert VidlundExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 25 granted of 40
  • PendingSystems And Methods For Trans-jugular Delivery Of A Prosthetic Heart ValveUSPTOApplication 19535945
  • PendingDevices And Methods For Delivering A Prosthetic Heart Valve Using Supra-annular SupportUSPTOApplication 19549546
  • PendingDevices And Methods For Cinching A Side-delivered Prosthetic Heart Valve For Delivery And Deployment In A Native AnnulusUSPTOApplication 19428845
Show all 40 patent records
  • Rivermark Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • Preceptis Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • CarePredictSimilar federal contract value in Medtech · null in contracts
  • Micron Biomedical, Inc.Similar federal contract value in Medtech · null in contracts
  • MaxQ Medical Inc.Similar federal contract value in Medtech · null in contracts
  • ADAPTIX IncSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .